Related Experiment Videos
Multidrug therapy in hospitalised leprosy cases
V D Tiwari1, M A Tutakne, G Singh
1Department of Dermatology, Venerology and Leprosy, Command Hospital SC, Pune, India.
Indian Journal of Leprosy
|January 1, 1988
Summary
This study tracked 58 leprosy patients undergoing multidrug therapy (MDT). Most reactions occurred early in multibacillary leprosy, with most cases showing subsided activity within 18 months.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Dermatology
Background:
- Leprosy remains a significant public health challenge, particularly in high endemic regions of India.
- Multidrug therapy (MDT) is the standard treatment, but treatment complications like reactions require careful monitoring.
Purpose of the Study:
- To analyze the clinical course and treatment outcomes of leprosy patients receiving MDT.
- To investigate the incidence, timing, and resolution of leprosy reactions during MDT.
Main Methods:
- Retrospective analysis of 58 leprosy patients (44 paucibacillary, 14 multibacillary) treated with MDT.
- Data collected on patient demographics, leprosy type, occurrence and type of reactions, and time to subsidence of activity.
Main Results:
- Leprosy reactions occurred in 13 patients (10 Type I, 3 Type II), predominantly in multibacillary cases within two months of MDT initiation.
- Majority of reactions (61.5%) subsided within 3-6 months.
- Disease activity subsided within 12 months for 65.5% of paucibacillary cases and within 18 months for multibacillary cases.
Conclusions:
- Early monitoring for reactions is crucial, especially in multibacillary leprosy patients starting MDT.
- While reactions can prolong treatment, leprosy activity typically subsides within the recommended treatment durations with MDT.